Studying Students at Risk for COVID-19

December 22, 2023 updated by: Sung Won Choi, University of Michigan

Monitoring Beliefs and Physiological Measures in Students at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology

The goal of this longitudinal observational study is to learn about how the COVID-19 has impacted and continues to impact students at the University of Michigan. We hope to determine whether a combination of (1) continuous heart rate obtained from wearable devices, (2) self-reported data from surveys and symptom logs, and (3) saliva samples can be used to help students self-monitor for infection and eventually be able to create a predictive model to detect illness early.

Study Overview

Status

Completed

Conditions

Detailed Description

The study was originally intended to last one year, however, it was expanded to follow the study participants over several years.

During this study, participants will be asked to:

  • Provide a baseline self-collected saliva sample
  • Download and use a suite of mobile apps (e.g., Fitbit, Social Rhythms, Roadmap 2.0)
  • Complete surveys online
  • Wear non-invasive Fitbit smartwatch
  • Grant the study team access to their university academic records (optional)

The study will use these tools to monitor participants' physical activity and mental health over the course of at least three years. The study will also examine whether there is a connection between mental health and academic performance.

Study Type

Observational

Enrollment (Actual)

2381

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • Michigan Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Students at the University of Michigan must be either coming to campus or reside in the United States.

Description

Inclusion Criteria:

  • Students at the University of Michigan who have moved back to Ann Arbor or who are completing schooling completely online.
  • For those completing school online, must be able to provide a mailing address within the United States where they can receive study tools
  • Possession of a smartphone (Apple or Andriod)
  • Ability to understand and demonstrate willingness to sign a written informed consent.

Exclusion Criteria:

  • Unwilling or unable to comply with the study procedures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of wearing Fitbit device
Time Frame: 4 months
Feasibility will will be defined as wearing the Fitbit watch at least 8 hours per day up to at least 5 days of the week
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survey completion
Time Frame: Up to 9 months
Completion will be measured by the number of participants who complete the study surveys
Up to 9 months
Saliva sample
Time Frame: Up to 4 months
Analyze samples to determine a possible early prediction/detection model for COVID-19
Up to 4 months
Continuous heart rate
Time Frame: Up to 8 months
Analyze heart rate data to determine a possible early prediction/detection model for COVID-19
Up to 8 months
Mental well-being
Time Frame: Up to 9 months
Assess participant mental well-being during the COVID-19 pandemic and if the use of health and well-being applications impacts self-rated well-being
Up to 9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sung Won Choi, MD, MS, University of Michigan

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 3, 2020

Primary Completion (Actual)

January 26, 2023

Study Completion (Actual)

April 18, 2023

Study Registration Dates

First Submitted

February 22, 2021

First Submitted That Met QC Criteria

February 22, 2021

First Posted (Actual)

February 23, 2021

Study Record Updates

Last Update Posted (Actual)

December 29, 2023

Last Update Submitted That Met QC Criteria

December 22, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on Wearable devices, saliva samples, survey measures

Subscribe